-
Mashup Score: 3VIDEO: Handelsman talks interdisciplinary guidance for cardio-renal-metabolic disease - 2 year(s) ago
PHILADELPHIA — In this Healio video exclusive, Yehuda Handelsman, MD, FACP, FNLA, FASCP, MACE, discussed the recently published multidisciplinary guidelines for diabetes and cardio-renal-metabolic diseases.The guidelines were published in December 2021 in the Journal of Diabetes and Its Complications.
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Albuminuria screening essential to guide therapy decisions in diabetic kidney disease - 2 year(s) ago
PHILADELPHIA — Chronic kidney disease assessment and monitoring by albuminuria and estimated glomerular filtration rate is necessary for delivering goal-directed therapies to people with diabetes, according to a speaker.The recent American Diabetes Association and Kidney Disease: Improving Global Outcomes (KDIGO) consensus report shows alignment on current recommendations for evidence-based
Source: www.healio.comCategories: Endocrinology, Latest HeadlinesTweet-
ICYMI: “We must move expeditiously from evidence to implementation of the breakthrough therapies that are poised to save lives, kidneys and hearts in patients with diabetes and CKD,” @HeartinDiabetes #HID2022 @YHandelsmanMD #CardioTwitter @KatherineTuttl8 https://t.co/UlCkwkcSkf
-
-
Mashup Score: 0
PHILADELPHIA — An interactive, data-driven tool can individualize care for people with type 2 diabetes while promoting shared decision-making between clinicians and patients, according to a speaker at the Heart in Diabetes CME conference.Type 2 diabetes is highly heterogenous with a wide range of risk factors, pathophysiological pathways and prognoses, and many therapeutic options, Richard
Source: www.healio.comCategories: Endocrinology, Latest HeadlinesTweet-
ICYMI“One of the biggest barriers will be provider engagement and implementation of advanced decision support as a routine in clinical practice. The implementation science is where we need a lot of work” @HeartinDiabetes #HID2022 @YHandelsmanMD @RpratleyMD https://t.co/JiH63OnrxL
-
-
Mashup Score: 4
PHILADELPHIA — In this Healio video exclusive, Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, discussed her presentation on sex-based disparities in diabetes and their impact on atherosclerotic CVD and HF.At the Heart in Diabetes CME conference, Michos, who is associate professor of medicine and associate director of preventive cardiology at the Ciccarone Center for the Prevention of
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
ICYMI: @ErinMichos highlights how despite there being greater diabetes prevalence among men, women experience greater CV risk @HeartinDiabetes #HID2022 @YHandelsmanMD #CardioTwitter @EndocrineToday https://t.co/t4DOsvHUdO
-
-
Mashup Score: 2Albuminuria screening essential to guide therapy decisions in diabetic kidney disease - 2 year(s) ago
PHILADELPHIA — Chronic kidney disease assessment and monitoring by albuminuria and estimated glomerular filtration rate is necessary for delivering goal-directed therapies to people with diabetes, according to a speaker.The recent American Diabetes Association and Kidney Disease: Improving Global Outcomes (KDIGO) consensus report shows alignment on current recommendations for evidence-based
Source: www.healio.comCategories: Endocrinology, Latest HeadlinesTweet-
ICYMI: “We must move expeditiously from evidence to implementation of the breakthrough therapies that are poised to save lives, kidneys and hearts in patients with diabetes and CKD,” @HeartinDiabetes #HID2022 @YHandelsmanMD #CardioTwitter @KatherineTuttl8 https://t.co/UlCkwkcSkf
-
-
Mashup Score: 0
PHILADELPHIA — An interactive, data-driven tool can individualize care for people with type 2 diabetes while promoting shared decision-making between clinicians and patients, according to a speaker at the Heart in Diabetes CME conference.Type 2 diabetes is highly heterogenous with a wide range of risk factors, pathophysiological pathways and prognoses, and many therapeutic options, Richard
Source: www.healio.comCategories: Endocrinology, Latest HeadlinesTweet-
ICYMI“One of the biggest barriers will be provider engagement and implementation of advanced decision support as a routine in clinical practice. The implementation science is where we need a lot of work” @HeartinDiabetes #HID2022 @YHandelsmanMD @RpratleyMD https://t.co/JiH63OnrxL
-
-
Mashup Score: 6
PHILADELPHIA — In this Healio video exclusive, Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, discussed her presentation on sex-based disparities in diabetes and their impact on atherosclerotic CVD and HF.At the Heart in Diabetes CME conference, Michos, who is associate professor of medicine and associate director of preventive cardiology at the Ciccarone Center for the Prevention of
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
In this Healio video exclusive, @ErinMichos discussed her presentation on sex-based disparities in diabetes and their impact on atherosclerotic CVD and HF @HeartinDiabetes #HID2022 @YHandelsmanMD #CardioTwitter @EndocrineToday https://t.co/t4DOsvHUdO
-
-
Mashup Score: 3
PHILADELPHIA — An interactive, data-driven tool can individualize care for people with type 2 diabetes while promoting shared decision-making between clinicians and patients, according to a speaker at the Heart in Diabetes CME conference.Type 2 diabetes is highly heterogenous with a wide range of risk factors, pathophysiological pathways and prognoses, and many therapeutic options, Richard
Source: www.healio.comCategories: Endocrinology, Latest HeadlinesTweet-
An interactive, data-driven tool can individualize care for people with type 2 diabetes while promoting shared decision-making between clinicians and patients @HeartinDiabetes #HID2022 @YHandelsmanMD #CardioTwitter @CardiologyToday @RpratleyMD https://t.co/JiH63OnrxL
-
-
Mashup Score: 5Albuminuria screening essential to guide therapy decisions in diabetic kidney disease - 2 year(s) ago
PHILADELPHIA — Chronic kidney disease assessment and monitoring by albuminuria and estimated glomerular filtration rate is necessary for delivering goal-directed therapies to people with diabetes, according to a speaker.The recent American Diabetes Association and Kidney Disease: Improving Global Outcomes (KDIGO) consensus report shows alignment on current recommendations for evidence-based
Source: www.healio.comCategories: Endocrinology, Latest HeadlinesTweet-
#CKD assessment and monitoring by albuminuria and eGFR is necessary for delivering goal-directed therapies to people with #diabetes @HeartinDiabetes #HID2022 @YHandelsmanMD #CardioTwitter @CardiologyToday @Nephronline @KatherineTuttl8 @Providence_Hlth https://t.co/UlCkwkcSkf
-
-
Mashup Score: 0
PHILADELPHIA — In this Healio video exclusive, Joshua J. Joseph, MD, MPH, FAHA, discussed the recent American Heart Association scientific statement on health equity in managing CV risk in type 2 diabetes.As Healio previously reported, the scientific statement, published in Circulation, is based on an extensive review of clinical trial results through June 2020 and addresses the managing of
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
ICYMI: Joshua J. Joseph, MD, MPH, FAHA, discussed the recent AHA statement on health equity in managing CV risk in type 2 diabetes @joshuajosephmd @OhioStateMed @EndocrineToday @HeartinDiabetes #HID2022 @YHandelsmanMD #CardioTwitter https://t.co/anxhfwlWVA
-
In this video exclusive, Yehuda Handelsman, MD, FACP, FNLA, FASCP, MACE, discussed the recently published multidisciplinary guidelines for diabetes and cardio-renal-metabolic diseases @HeartinDiabetes #HID2022 @YHandelsmanMD #CardioTwitter @EndocrineToday https://t.co/3zR7mFZA99